RM vs VRTX · P/E 7.5, rev $588.5M vs P/E 30, rev $12.00B
Regional Management Corp (RM) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Regional Management Corp (RM) is a credit services company listed on NYSE.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported RM revenue for 2024-12-31 was $588.5M. Net income was $41.2M. Revenue was up 6.7% from 2023-12-31 to 2024-12-31. RM currently screens at market cap $339.8M and trailing P/E 7.5.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
RM currently screens at market cap $339.8M and trailing P/E 7.5. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the RM and VRTX stock pages for the full models.
Not investment advice.